Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma

  1. Zhu, A.X.
  2. Dayyani, F.
  3. Yen, C.-J.
  4. Ren, Z.
  5. Bai, Y.
  6. Meng, Z.
  7. Pan, H.
  8. Dillon, P.
  9. Mhatre, S.K.
  10. Gaillard, V.E.
  11. Hernandez, S.
  12. Kelley, R.K.
  13. Sangro, B.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Argitalpen urtea: 2022

Alea: 28

Zenbakia: 16

Orrialdeak: 3537-3545

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-21-3275 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus